New Effective Treatments for Stage 4 Cancer: Innovations in Oncology
Don't know where to start? Leave us a request, and the Booking Health team will arrange your trip for treatment in Germany, where you will improve the quality of life and health.
- Principles of Cancer Treatment in Classical Medicine
- Disadvantages and limitations of classical cancer therapy
- Principles of cancer treatment using immunological techniques (immunotherapy)
- Therapeutic hyperthermia
- Infusion therapy to activate the immune system
- Chemoembolization in cancer treatment
- Success Rates and Prognosis with New Treatments
- Leading International Options for Cutting-Edge Cancer Treatment
- Treatment of Advanced Cancers in the Specialised German Clinics
- Indications for comprehensive therapy in stage 4 cancer
- Organisation of treatment in Germany for international patients
- Frequently asked questions of our patients
According to official statistics from the WHO in 2022, oncological diseases are now the cause of one in every six deaths worldwide. This has encouraged the international medical community to develop new cancer treatment methods and increase the effectiveness of the already existing ones. This is particularly important for patients with advanced stages of the disease, where due to the tumor's metastatic spreading, almost the entire body is affected.
In 2018 the Study of the Immune System in Patients with Malignancies was awarded the Nobel Prize in Medicine. The activation of a patient's own immunity and the training of his immune cells to recognize the tumor is the basis of safe therapy for healthy tissues. This can be used even in the advanced stages of the disease. It is possible in customized treatment, to adapt to the characteristics of the disease’s progression in a particular patient.
New effective treatments for stage 4 cancer are emerging from ongoing research in the world, impacting life expectancy and guiding consultants to recommend advanced screening and test procedures. These developments are raising awareness among patients and healthcare providers, while also prompting insurance companies to reevaluate coverage for emergency interventions, potentially improving access to cutting-edge therapies.
Principles of Cancer Treatment in Classical Medicine
Classical medicine offers many possibilities in the treatment of cancer, which can affect a malignant neoplasm directly or through a modification of the tumor’s microenvironment:
- Surgical treatment includes total or partial tumor removal, as well as tissue sampling for a histological examination. At the advanced stages of cancer, these operations are rare. It is impossible to completely remove all metastases of a large tumor that has sprouted into adjacent organs.
- Radiation therapy is performed to reduce the malignant neoplasm in size or prevent relapse after surgery. Modern hospitals also provide stereotactic radiation therapy using the Gamma Knife or the CyberKnife systems. This is a targeted tumor removal that does not require a surgical intervention. The directed beam of ionizing radiation reaches the tumor through intact skin.
- Chemotherapy includes the prescription of drugs, which block the reproduction of cancer cells. Unfortunately, chemotherapeutic drugs also affect healthy tissues.
- Symptomatic treatment includes anesthetic therapy; antiemetic drugs rich in proteins or parenteral nutrition. The symptomatic treatment does not eliminate the cause of the disease but improves the patient's quality of life to a certain point.
Depending on both the tumor type and the stage of the process, these methods can be used in monotherapy or combination (for example radiation therapy is complemented by symptomatic treatment, surgery is followed by chemotherapy, etc.). Recent breakthroughs in treating stage 4 cancer span multiple specialties, from hematology to neurology, with promising results in prostate, lung, colon, liver, pancreatic, ovarian, cervical, and bone cancers, as well as pediatric malignancies. Advanced imaging techniques, including high-resolution ultrasound, are enhancing early detection and treatment monitoring across these cancer types, offering new hope for patients with advanced-stage disease.
Disadvantages and Limitations of Classical Medicine Cancer Therapy
Despite the extensive arsenal of classical techniques available and the vast practical experience of their use, the classical approach to cancer treatment has several limitations. These include:
- Injury – to ensure surgical access to a tumor, the healthy tissues are inevitably destroyed. This is dangerous because the regeneration processes in cancer patients are weak, and such patients are prone to infections.
- Toxicity – chemotherapy drugs inhibit the basic processes of cellular metabolism by destroying not only cancer cells but also healthy cells. Also, during chemotherapy, the bloodstream has the toxic decomposition products of the tumor, which causes damage to the liver and kidneys.
- The impossibility of a complete recovery– at IV stage cancer a limited range of treatment methods are applied. All of these methods aim to suppress tumor growth and prolong life but do not cure the patient.
- Suppression of the patient's immune system– T-cell and B-cell immunity are inhibited.
- High costs – often chemotherapy is carried out for several months or even years. For a patient who pays for the treatment himself, it becomes quite expensive. Surgical interventions, especially brain surgeries, also have high prices.
Considering the results of classical oncopathology treatment regimens, scientists are developing new, more effective, and less traumatic therapeutic approaches for the body. New approaches are revolutionizing patient care, with nurses now trained to guide patients through both common and alternative therapies, while also educating them about the signs and symptoms, such as the presence of a lump, blood in stool, or chronic pain. These advancements have a significant impact on healthcare in state and private healthcare facilities.
Principles of Cancer Treatment Using Immunological Techniques (immunotherapy)
The main principle of this treatment is the restoration of the body's own defenses, the immune system, and nonspecific antitumor mechanisms. The therapy provides a long-term result and the complete elimination of cancer cells. In classical medicine, the tumor and its metastases are removed artificially. However, alternative methods activate an "internal protection", which reveals metastases and groups of atypical cells, which may not be detected by even the most accurate medical equipment.
The conception of integrative medicine is characterized by the following aspects:
- Good tolerability, minimal side effects
- Targeted influence on tumor foci without affecting healthy tissues
- The possibility of use in patients with critical conditions (for example, with a decreased kidney or liver function or allergies)
- Achievement of a good result even at advanced stages of cancer with metastasis to body areas at a distance from the primary tumor
- Activation of patient’s antitumor immunity, restoration of T and B cells’ ability to detect and destroy abnormal tumor cells
- Permanent results without the need for constantly repeated treatment courses
In leading European Cancer Centres, the doctors practice an integrated approach for the treatment of grade 4 cancer. In the Europe of the 21st century, the integrative approach includes potentially useful classical medical methods for the patient (for example, surgical removal of a tumor part) and complements these with alternative methods. It is a proven fact that the individual concept of comprehensive treatment gives the best clinical outcome.
Immunotherapy with dendritic cells has emerged as an innovative and promising immunological treatment. Over the past decade, dendritic cell therapy has gained significant recognition among oncologists worldwide, with German medical centers being at the forefront of its development and implementation. The treatment is particularly well-tolerated, with minimal side effects compared to conventional therapies. The cost of dendritic cell immunotherapy typically ranges from 20,000 to 38,000 EUR, varying based on the complexity of the case and the need for additional therapeutic interventions.
To better understand this innovative treatment, we spoke with Professor Frank Gansauge, one of the pioneers in dendritic cell therapy who has been successfully implementing this method since 2001. His clinic has demonstrated significant success in treating various types of cancer, including gastrointestinal tumors, prostate cancer, breast cancer, melanoma, and glioblastoma, with documented cases of extended survival rates and complete recovery.
Therapeutic Hyperthermia
Hyperthermia is the heating of a body part, an anatomical area, or the whole body to an effective temperature of 38-42 °C. The normal vessels and capillary networks do not have enough time to be formed in fast-growing malignancies. Therefore, with a temperature increase their blood flow decreases to almost zero. Without an adequate blood supply, the tumor and metastases do not receive the necessary nutrients and are quickly destroyed by the influence of their own toxic metabolic products. During this procedure the periods of the body heating and cooling alternate, so it is well tolerated by patients.
One of the innovative types of thermotherapy is laser-induced interstitial thermotherapy (LITT). This procedure is performed using specialized equipment– the Nd: YAG-laser, which consists of neodymium-doped yttrium aluminum garnet crystal. With the help of a miniature fiberglass applicator, the doctor delivers laser radiation directly to the tumor. During the treatment, the temperature in the target area reaches between 60-110°C, which leads to the tumor’s destruction.
LITT procedure is successfully used in inoperable tumors of the liver, kidneys, lungs, breast, prostate, and other organs. LITT also allows doctors to carefully destroy metastases in parenchymal organs and lymph nodes. This procedure is the treatment of choice in patients with metastases in the liver and lungs who may not survive after surgery.
The cost of a comprehensive medical program that includes hyperthermia and infusion therapy typically ranges between 18,000 and 19,000 euros, varying based on the hospital's level and the treating physician's expertise.
Infusion Therapy to Activate the Immune System
Infusion therapy includes the introduction of many substances:
- Regeneresen is a group of injectable drugs that restore the protein biosynthesis disturbed by the formation of a tumor. The high selectivity of RNA in the composition of the drug, allows it to act precisely on the organs affected by cancer.
- Artesunate is a natural medication, the creation of which was awarded the Nobel Prize in 2015. The drug destroys cancer cells and blood vessels feeding the tumor.
- Curcumin is a natural plant pigment that causes tumor cell apoptosis and inhibits tumor metastasis. The reports of clinical investigations of curcumin in cancer treatment were published in Clinical Gastroenterology Hepatology and Molecules journals, as well as on the Australian Science Network website.
- GcMAF is a modified human protein involved in the activation of macrophages. These are the cells of the immune system responsible for recognizing and destroying atypical cancer cells.
- Hypericin is a red, vegetable pigment with the properties of an effective natural photosensitizer. Hypericin is used in photodynamic cancer therapy, which implies the destruction of pretreated atypical cells using laser radiation.
Depending on the type of malignancy and the results of histological diagnostics, other rare and specialized methods may also be used. The cost of a comprehensive treatment program that includes hyperthermia and infusion therapy typically ranges between 18,000 and 19,000 euros, varying based on the hospital's level and the treating physician's expertise.
Chemoembolization in Cancer Treatment
Transarterial chemoembolization (TACE) has a local effect on the tumor, using high dosages of chemotherapy drugs. Embolization is successfully used in the treatment of tumors with active blood supply, for example; liver cancer, breast cancer, and colorectal tumors. Unlike classical systemic chemotherapy, chemoembolization:
- Has a targeted effect on the tumor and due to the localized action is less toxic to the surrounding healthy tissues.
- Provides a higher concentration of chemotherapeutic agents in the target area.
- Has a longer effect, because blood flow through the arteries is blocked, as a result of which medications cannot enter the systemic circulation.
- Stimulates tumor necrosis and destruction by blocking the blood supply and depriving the tumor of the necessary nutrients.
Due to its excellent tolerability, TACE is performed on an outpatient basis and requires only a short inpatient stay. At the preparation stage, doctors conduct angiography, which is a contrast radiography allowing for precise imaging of the tumor vessels. The leading cancer clinics use only angiography devices with high image accuracy since it is important to identify all sources of blood supply. Also, CT, MRI, and PET-CT results are taken into account.
During the procedure, a thin catheter is inserted into the femoral artery, which moves through the blood vessels and reaches the target area (for example, the hepatic artery). The next step is chemotherapy drug injection into the tumor. The artery is "blocked" with an embolus. There may also be used drug-coated microspheres (DEM), for example, LifePearl or HepaSphere microspheres.
Once TACE is completed, the catheter is removed and the femoral artery is covered with a pressure bandage for 3 hours. During the first few hours, the patient should stay in bed, after which he can return to his usual life. The next day after the intervention, the patient should have a follow-up CT scan to evaluate the effectiveness of treatment. If necessary, TACE will be repeated several times to completely block the smallest tumor vessels.
The cost of chemoembolization varies significantly, ranging from 6,500 to 24,000 EUR, depending on the hospital's level, the complexity of the case, and the tumor location. For instance, treating liver metastases is technically simpler and therefore less expensive than addressing adrenal metastases.
To gain deeper insights into the practical aspects and effectiveness of chemoembolization, we spoke with Professor Thomas Vogl, Head of the Department of Radiology at the University Hospital Frankfurt. With over 23 years of experience at this institution and performing 8-10 regional chemotherapy procedures daily, Prof. Vogl has established himself as one of the leading experts in interventional oncology. His department has successfully carried out approximately 10,000 chemoembolization procedures, demonstrating remarkable results in treating various types of cancer, particularly liver, lung, and metastatic tumors.
Success Rates and Prognosis with New Treatments
The advancement of stage IV cancer treatment options has brought encouraging improvements and hope. Different therapeutic approaches show varying degrees of success, with some newer methods demonstrating particularly promising results.
| Treatment | 2-Year Survival Rate* | Response Rate** | Indications |
| Classical chemotherapy | 20-30% | 10-20% | diverse cancer types |
| Immunotherapy | 30-40% | 40-50% | diverse cancer types |
| Targeted therapies | 35-45% | 35-45% | diverse cancer types |
| LITT | 25-35% | 15-25% | liver, brain tumors |
| CAR T-cell therapy | 40-50% | 30-40% | hematologic cancers |
| Hyperthermia + Immunotherapy | 35-45% | 65-75% | diverse cancer types |
| Chemoembolization | 40-50% | 60-80% | liver cancer, liver metastasis, breast cancer, etc. |
*Booking Health data. Survival rates vary widely depending on the type of cancer, the patient's condition, and specific circumstances.
**Booking Health data. Response rate is the number of patients who show improvement after treatment.
Recent data suggest that success rates continue to improve as treatment protocols evolve and new combinations are discovered. Healthcare professionals now have more tools than ever to create personalized treatment plans and achieve better outcomes.
Leading International Options for Cutting-Edge Cancer Treatment
The treatment of stage 4 cancer has evolved, with international medical centers standing at the forefront of innovation, such as:
- MD Anderson Cancer Center (USA) that has revolutionized targeted therapy approaches through sophisticated molecular profiling
- German Cancer Research Center (DKFZ) that excels in personalized immunotherapy development
- Gustave Roussy Institute (France) that leads European immunotherapy research with complex protocols
In addition to immunotherapy, advanced treatment options now include proton beam therapy, which is available at specialized centers in Switzerland and Germany. Selected research hospitals worldwide are conducting promising CRISPR gene editing trials. New variants of CAR T-cell therapy are being tested in international clinical trial networks.
Specialized German clinics have gained particular recognition for their integrative cancer treatment for stage 4 that combines:
- Conventional and alternative protocols working together
- Comprehensive approaches addressing both disease and overall wellbeing
- Access to novel treatments, clinical trials
- Personalized therapy plans based on molecular and genetic profiling
Treatment of Advanced Cancers in the Specialised German Clinics
Only a limited number of specialized Cancer Centers can offer patients with stage IV cancer the medical equipment and the services of qualified specialists for alternative therapy. The most significant results in this area are demonstrated by the Clinic of Advanced Biological Medicine in Frankfurt am Main and its Head, Dr. Med. Gerhard Siebenhüner. Also, the Department of Adult and Paediatric Diagnostic, Interventional Radiology at the University Hospital Frankfurt am Main with its Head Prof. Dr. Med. T. Vogl, leads the LITT and TACE areas.
The therapeutic methods are applied in the following sequence:
- Consultation and immunotherapy by Dr G. Siebenhüner, the course lasts five days
- Consultation with Prof. Vogl, TACE procedure planning
- Follow-up MRI and determination of chemoembolization scope
- TACE procedure (up to twenty-five minutes per area)
- Inpatient monitoring for three hours, follow-up CT scan
- Repeated examination by Prof. Vogl, after which the patient can leave the clinic
- After one day of recovery, the TACE procedure will be repeated in another area (if necessary)
Another effective combination of treatments is offered through the partnership of specialized immunotherapy centers and Prof. Dr. Med. Frank Gansauge's clinic. This program combines infusion immunotherapy with advanced dendritic cell treatment. The treatment protocol includes:
- Initial consultation and blood collection for vaccine manufacturing
- Optional 7-day intensive immunotherapy course during the vaccine preparation period, including specialized infusions
- Comprehensive rehabilitation program including ergotherapy, oxygen treatments, and physiotherapy
- Follow-up examination and assessment of the patient's condition
- Administration of the personalized LANEX-DC dendritic cell vaccine
- Final consultation and development of further treatment recommendations
The complete program typically spans about 9 days, accounting for the time needed for vaccine preparation. The treatment plan is highly individualized and can be adjusted based on the patient's condition and response to therapy.
Indications for Comprehensive Therapy in Stage 4 Cancer
While stage four cancer has traditionally been considered incurable, modern combination therapies are changing this perspective. Recent clinical trials from 2022-2024 have documented cases of long-term remissions across various cancer types, and even aggressive brain tumors like glioblastoma. These results are leading oncologists to cautiously discuss the possibility of such remissions becoming permanent cures.
Comprehensive therapy in stage 4 cancer has demonstrated significant efficacy in treating numerous advanced-stage cancers, including:
- Bowel cancer
- Rectal cancer
- Pancreatic cancer
- Breast cancer
- Lung cancer
- Stomach cancer
- Uterine cancer
- Ovarian cancer
- Thyroid cancer
- Brain tumors, including glioblastoma
- Liver cancer
- Prostate cancer
- Melanoma and other skin cancers
To determine the most appropriate treatment program, patients should consult with medical experts. Booking Health brings extensive expertise in international medical tourism, facilitating urgent appointments with leading specialists, providing comprehensive cost planning, and ensuring individual case evaluation by medical boards. Each patient receives personalized support through a dedicated medical coordinator and interpreter, with the complete organization of treatment.
The effectiveness of comprehensive treatment programs is best illustrated through the success stories of cancer survivors. Diagnosed with stage 4 glioblastoma in January 2024, Daria Rogers received dendritic cell immunotherapy in Germany, combined with standard treatments. Against traditional prognoses, her follow-up MRI scans showed no evidence of cancer progression. "I wouldn't have been here sitting right now talking to you if it wasn't for dendritic cell treatment," shares Daria. You can watch Daria's full inspiring journey to recovery in our video interview.
The Organization of Treatment in Germany for International Patients
Both citizens of the country and international patients can undergo the comprehensive treatment of stage IV cancer in Germany. If you are seeking medical care from a foreign clinic for the first time, it will be safer and more effective to charge with the organization of treatment. Booking Health is a medical tourism operator that helps patients from seventy-five different countries undergo innovative cancer treatments abroad.
With due consideration and all of the subtleties of care for patients with the fourth stage cancer, the Booking Health experts will help you with all the important issues:
- Confirmation of appropriate choice of clinic and direct communication with the attending physician
- Preliminary preparation of the personalized treatment program, without repeating previous examinations
- Provision of a favorable cost of clinic services, without any extra charges and coefficients for foreigners (saving up to 50%)
- Doctor’s appointment on the desired date
- Control of the medical program at all its stages
- Assistance with buying and forwarding medicines
- Communication with the clinic after treatment completion
- Monitoring of invoices and return of any unspent funds
- Organization of any additional examinations
- Top-class service for booking hotels, airline tickets, transfers, interpreting services
To get professional help in planning innovative cancer treatments abroad, leave your request on the official Booking Health website. A competent medical consultant will discuss with you all of the medical details and help you correctly prepare for the flight and treatment.
Frequently asked questions of our patients
New effective treatments for stage IV cancer include immunotherapies, targeted therapies, CAR T-cell therapy, and advanced radiation techniques such as proton therapy. These treatments aim to improve survival rates and quality of life by targeting cancer cells more precisely.
CAR T-cell therapy involves modifying a patient's T-cells to express chimeric antigen receptors (CARs) that can recognize and attack cancer cells. This personalized treatment boosts the immune system's ability to target and destroy advanced-stage tumors effectively.
Proton therapy provides highly precise radiation treatment, minimizing damage to surrounding healthy tissues. This is particularly beneficial for stage IV cancer patients, as it reduces side effects and allows for higher doses of radiation to be delivered directly to the tumor.
Yes, emerging targeted therapies are continuously being developed to target specific genetic mutations and proteins associated with cancer growth. These therapies offer a more personalized approach to treatment, potentially leading to better outcomes for stage IV cancer patients.
Patients can access these new treatments through specialized cancer centers and hospitals in Germany. Many clinics participate in international clinical trials, offering patients the opportunity to receive cutting-edge therapies. Consultation with a medical specialist is essential to determine eligibility and develop an appropriate treatment plan.
Choose treatment abroad and you will be sure to get the best results!
Authors:
This article was edited by medical experts, board-certified doctors Dr. Nadezhda Ivanisova, and Dr. Sergey Pashchenko. For the treatment of the conditions referred to in the article, you must consult a doctor; the information in the article is not intended for self-medication!
Our editorial policy, which details our commitment to accuracy and transparency, is available here. Click this link to review our policies.
Sources:
Read:
Cancer immunotherapy in Germany
Dendritic cell therapy in cancer treatment in Germany - Vaccination against cancer
Adaptive Cell Therapy: CAR T-Cell Therapy
